Delivery Order SPE2DB20D2001-SPE2DB25FPNEE
- Not listed
- The Defense Logistics Agency awarded a $2,711.36 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen units on July 18, 2025, with a completion date of July 21, 2025. This non-set-aside contract represents a specific product delivery under the company's broader pharmaceutical supply relationship with the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $23,423.40 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pens on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's...
- The Defense Logistics Agency awarded a $3,205.08 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors. The contract, with an ultimate completion date of July 21, 2025, represents a non-competitive delivery against AmerisourceBergen's broader indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $10,414.19 delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 mL pen injections (0.5 mL units) under a firm fixed-price contract. The award was made on July 18, 2025, with an ultimate completion date of July 21, 2025, and is being performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order carries no set-aside designation, indicating it was competitively awarded on an open basis. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zepbound 12.5 mg/0.5 ml pens valued at $7,543.07 on July 18, 2025, with completion targeted for July 21, 2025. This firm fixed-price delivery order, which received no set-aside designation, will be performed at AmerisourceBergen's Corporate Office facility in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction within the company's existing indefinite delivery vehicle with DLA...
- The Defense Logistics Agency awarded a $24,689.72 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The product delivery supports federal medical procurement needs, particularly for military and veteran...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $12,833.77, is for the delivery of the pharmaceutical product Zepbound 5 mg/0.5 ml pen. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of May 15, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The federal contract award details a $1,404.79 delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Zepbound 7.5 mg/0.5 ml pens, a medical product used for various healthcare applications. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The $1,525.20 firm fixed price delivery order is for the supply of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a medical product. The contract has an ultimate completion date of July 14, 2025 and was awarded on July 11, 2025. It is not designated as a set-aside contract, indicating open...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,482.89 firm fixed-price contract is for the delivery of the pharmaceutical product ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML. The award has an ultimate completion date of June 23, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB25FPNEEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,812.90 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pens on July 18, 2025, with completion scheduled for July 21, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award under the company's existing pharmaceutical supply contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a child order under this prime vendor contract, the delivery order leverages the company's established relationship with the Defense Logistics Agency to supply critical pharmaceutical products supporting military healthcare operations. AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor providing a comprehensive range of medications, vaccines, and medical supplies to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard, demonstrating its critical role in the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 7/18/25 |